首页 > 最新文献

Journal of Nepal Paediatric Society最新文献

英文 中文
Utility of Sequential Organ Failure Assessment Score in Prognosticating sick Children in Paediatric Intensive care Unit 序贯器官衰竭评估评分在儿科重症监护病房患儿预后中的应用
Q4 Medicine Pub Date : 2022-11-27 DOI: 10.3126/jnps.v42i1.41178
Raju Kafle, Shah Sanjeev, Gupta Binod Kumar
Introduction: There are number of scoring systems to assess the morbidity and mortality of sick children in intensive care unit. Out of these scoring systems our study was designed to look for the utility of Sequential Organ Failure Assessment (SOFA) score which is less time consuming and simple to apply as a predictor of mortality in sick children admitted in Paediatric Intensive Care Unit (PICU).Methods: This was a prospective observational study done in PICU of Universal College of Medical Sciences, Bhairahawa, Nepal. Recruited patients were all critically sick children above one year who stayed in hospital above 72 hours and underwent all necessary evaluation, and were followed up until they were discharged or deceased. Initial SOFA score was calculated within 24 hours of admission (SOFA T0) and again calculated after 72 hours (SOFA T72). Delta SOFA score was calculated as the change in SOFA scores over 72 hours (SOFA T0 - SOFA T72). The primary outcome was in-hospital mortality.Results: When compared to outcome, the non survivors had high mean initial SOFA (T0) 11.51 ± ences ec ing 3.001 (P < 0.001), mean SOFA after 72 hours (T72) was 15.51 ± 4.026 (P < 0.001) and mean delta SOFA (T0-T72) was 4.58 ± 2.59 (P = 0.166) as compared to survivors. Delta SOFA was not significantly associated with outcome (P = 0.166). The initial SOFA score T0 > / = 11 predicted a mortality of 70.90% and SOFA T72 score of >/=15 predicted a mortality of 81.60% but delta sofa >/= 4 predicts a mortality of only 43.60%. Area under receiver operating characteristic (ROC) curve for SOFA TO was 0.769, for SOFA T72 was 0.890 and for delta SOFA was 0.604 and thus, showing excellent discriminative power for SOFA 72 for predicting mortality.Conclusions: The SOFA score demonstrated fair to good accuracy for predicting mortality when applied to sick children > 1 year admitted in PICU. Our study showed both initial SOFA T0 and SOFA at 72 hours predict mortality with good accuracy but SOFA at 72 hours is a better predictor of mortality as compared to initial and delta SOFA scores.
有许多评分系统来评估重症监护病房患病儿童的发病率和死亡率。在这些评分系统中,我们的研究旨在寻找顺序器官衰竭评估(SOFA)评分的效用,该评分耗时更少,且易于应用于儿科重症监护病房(PICU)住院患儿的死亡率预测。方法:这是一项前瞻性观察性研究,在尼泊尔Bhairahawa的Universal College of Medical Sciences PICU完成。招募的患者均为1岁以上住院72小时以上的危重患儿,并接受所有必要的评估,随访至出院或死亡。入院24小时内计算初始SOFA评分(SOFA T0), 72小时后再次计算SOFA评分(SOFA T72)。Delta SOFA评分计算为SOFA评分在72小时内的变化(SOFA T0 - SOFA T72)。主要终点是住院死亡率。结果:与预后相比,非幸存者的平均初始SOFA (T0)为11.51±3.001 (P < 0.001), 72小时后平均SOFA (T72)为15.51±4.026 (P < 0.001),平均δ SOFA (T0-T72)为4.58±2.59 (P = 0.166)。Delta SOFA与预后无显著相关(P = 0.166)。初始SOFA评分T0 >/= 11预测死亡率为70.90%,SOFA T72评分>/=15预测死亡率为81.60%,而delta SOFA评分>/= 4预测死亡率仅为43.60%。SOFA TO的受试者工作特征(ROC)曲线下面积为0.769,SOFA T72的受试者工作特征(ROC)曲线下面积为0.890,delta SOFA的受试者工作特征(ROC)曲线下面积为0.604,因此,SOFA 72对预测死亡率具有良好的判别能力。结论:SOFA评分在预测PICU住院1 ~ 10年患儿死亡率方面具有良好的准确性。我们的研究表明,初始SOFA T0和72小时的SOFA都能准确预测死亡率,但与初始和delta SOFA评分相比,72小时的SOFA能更好地预测死亡率。
{"title":"Utility of Sequential Organ Failure Assessment Score in Prognosticating sick Children in Paediatric Intensive care Unit","authors":"Raju Kafle, Shah Sanjeev, Gupta Binod Kumar","doi":"10.3126/jnps.v42i1.41178","DOIUrl":"https://doi.org/10.3126/jnps.v42i1.41178","url":null,"abstract":"Introduction: There are number of scoring systems to assess the morbidity and mortality of sick children in intensive care unit. Out of these scoring systems our study was designed to look for the utility of Sequential Organ Failure Assessment (SOFA) score which is less time consuming and simple to apply as a predictor of mortality in sick children admitted in Paediatric Intensive Care Unit (PICU).\u0000Methods: This was a prospective observational study done in PICU of Universal College of Medical Sciences, Bhairahawa, Nepal. Recruited patients were all critically sick children above one year who stayed in hospital above 72 hours and underwent all necessary evaluation, and were followed up until they were discharged or deceased. Initial SOFA score was calculated within 24 hours of admission (SOFA T0) and again calculated after 72 hours (SOFA T72). Delta SOFA score was calculated as the change in SOFA scores over 72 hours (SOFA T0 - SOFA T72). The primary outcome was in-hospital mortality.\u0000Results: When compared to outcome, the non survivors had high mean initial SOFA (T0) 11.51 ± ences ec ing 3.001 (P < 0.001), mean SOFA after 72 hours (T72) was 15.51 ± 4.026 (P < 0.001) and mean delta SOFA (T0-T72) was 4.58 ± 2.59 (P = 0.166) as compared to survivors. Delta SOFA was not significantly associated with outcome (P = 0.166). The initial SOFA score T0 > / = 11 predicted a mortality of 70.90% and SOFA T72 score of >/=15 predicted a mortality of 81.60% but delta sofa >/= 4 predicts a mortality of only 43.60%. Area under receiver operating characteristic (ROC) curve for SOFA TO was 0.769, for SOFA T72 was 0.890 and for delta SOFA was 0.604 and thus, showing excellent discriminative power for SOFA 72 for predicting mortality.\u0000Conclusions: The SOFA score demonstrated fair to good accuracy for predicting mortality when applied to sick children > 1 year admitted in PICU. Our study showed both initial SOFA T0 and SOFA at 72 hours predict mortality with good accuracy but SOFA at 72 hours is a better predictor of mortality as compared to initial and delta SOFA scores.","PeriodicalId":39140,"journal":{"name":"Journal of Nepal Paediatric Society","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43539207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinico-epidemiological Profile of Children with Diphtheria in Tertiary Care Hospital of Nepal 尼泊尔三级医院儿童白喉临床流行病学概况
Q4 Medicine Pub Date : 2022-11-27 DOI: 10.3126/jnps.v42i1.40546
S. Basnet, L. Shrestha, L. Bajracharya
Introduction: This study was conducted with the aim to describe the clinical presentation of diphtheria in children, relationship between clinical disease and immunization status, complications of the disease and adverse events due to anti diphtheria serum (ADS).Methods: All patients admitted at Tribhuvan University Teaching Hospital, Kathmandu from July 2016 to November 2018 with clinical diagnosis of diphtheria were included in this study.Results: There were total 12 children and age ranged from five to 15 years, out of which seven (58%) were males and five (42%) were females. All of them were immunized except one whose immunization status was unknown. All of them had tonsillopharyngeal diphtheria. Four patients (33%) also had nasal and five (42%) patients had additional laryngotracheal diphtheria. Seven patients had bull neck on presentation. Four patients had airway obstruction due to laryngotracheal diphtheria requiring tracheostomy. Throat swab for Corynebacterium Diphtheria by Albert stain and Gram stain were positive in 10 patients, and in nine, diagnosis was confirmed by culture. Six patients (50%) were given anti diphtheria serum (ADS) out of which four patients (66.66%) developed anaphylaxis. Myocarditis was the commonest complication seen in four patients (25%). All children with myocarditis developed complete heart block (CHB) and none of them survived.Conclusions: Tonsillopharyngeal diphtheria was the most common clinical presentation and myocarditis was highly fatal complication. This study emphasizes on the need for careful surveillance, early laboratory confirmation and careful administration of ADS in patients with clinical diagnosis of diphtheria.
引言:本研究旨在描述儿童白喉的临床表现、临床疾病与免疫状态的关系、疾病并发症以及抗白喉血清(ADS)引起的不良事件,本研究纳入了2016年7月至2018年11月临床诊断为白喉的加德满都。结果:共有12名儿童,年龄从5岁到15岁不等,其中7名(58%)为男性,5名(42%)为女性。除了一名免疫状况不明的人外,所有人都接种了疫苗。他们都患有扁桃体咽白喉。4名患者(33%)也患有鼻腔白喉,5名患者(42%)患有喉气管白喉。有7名患者在就诊时出现了牛颈。4名患者因喉气管白喉导致气道阻塞,需要进行气管造口术。10例患者咽拭子Albert染色和Gram染色检测白喉棒状杆菌阳性,9例患者经培养确诊。6名患者(50%)服用抗白喉血清(ADS),其中4名患者(66.66%)出现过敏反应。心肌炎是四名患者中最常见的并发症(25%)。所有患有心肌炎的儿童都出现了完全性心脏传导阻滞(CHB),没有一例存活下来。结论:扁桃体-白喉是最常见的临床表现,心肌炎是最致命的并发症。这项研究强调了对临床诊断为白喉的患者进行仔细监测、早期实验室确认和谨慎使用ADS的必要性。
{"title":"Clinico-epidemiological Profile of Children with Diphtheria in Tertiary Care Hospital of Nepal","authors":"S. Basnet, L. Shrestha, L. Bajracharya","doi":"10.3126/jnps.v42i1.40546","DOIUrl":"https://doi.org/10.3126/jnps.v42i1.40546","url":null,"abstract":"Introduction: This study was conducted with the aim to describe the clinical presentation of diphtheria in children, relationship between clinical disease and immunization status, complications of the disease and adverse events due to anti diphtheria serum (ADS).\u0000Methods: All patients admitted at Tribhuvan University Teaching Hospital, Kathmandu from July 2016 to November 2018 with clinical diagnosis of diphtheria were included in this study.\u0000Results: There were total 12 children and age ranged from five to 15 years, out of which seven (58%) were males and five (42%) were females. All of them were immunized except one whose immunization status was unknown. All of them had tonsillopharyngeal diphtheria. Four patients (33%) also had nasal and five (42%) patients had additional laryngotracheal diphtheria. Seven patients had bull neck on presentation. Four patients had airway obstruction due to laryngotracheal diphtheria requiring tracheostomy. Throat swab for Corynebacterium Diphtheria by Albert stain and Gram stain were positive in 10 patients, and in nine, diagnosis was confirmed by culture. Six patients (50%) were given anti diphtheria serum (ADS) out of which four patients (66.66%) developed anaphylaxis. Myocarditis was the commonest complication seen in four patients (25%). All children with myocarditis developed complete heart block (CHB) and none of them survived.\u0000Conclusions: Tonsillopharyngeal diphtheria was the most common clinical presentation and myocarditis was highly fatal complication. This study emphasizes on the need for careful surveillance, early laboratory confirmation and careful administration of ADS in patients with clinical diagnosis of diphtheria.","PeriodicalId":39140,"journal":{"name":"Journal of Nepal Paediatric Society","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46756292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Efficacy and Safety of Once Daily versus Twice Daily Dosing of Caffeine Citrate in Apnea of prematurity: a Randomised Control Tria 每日一次与每日两次枸橼酸咖啡因治疗早产儿呼吸暂停的疗效和安全性:一项随机对照试验
Q4 Medicine Pub Date : 2022-11-27 DOI: 10.3126/jnps.v42i1.37173
Farooq Syed, Sandesh Kini, Abdul Majeed
Introduction: Caffeine citrate is widely used for prevention of apnea of prematurity and helps in successful extubation from mechanical ventilation. The optimum caffeine dose in preterm infants with apnea of prematurity has been extensively investigated with varied results. The objective of our study was to compare the efficacy and safety of once versus twice daily maintenance dose of caffeine citrate in premature infants with apnea.Methods: In this study, preterm neonates with gestational age of 28 to 34 weeks, with evidence of apnea of prematurity were included. Both groups received a 20 mg / kg loading dose of caffeine citrate followed by a maintenance dose of 2.5 mg / kg every 12-hour-interval in group 1 and 5 mg / kg every 24-hour-interval in group 2, either orally or by intravenous infusion. Response to treatment, duration to achieve full feeds, possible adverse reactions were evaluated and compared among the two groups.Results: Among two groups, group 1 had early reduction in number of apneic episodes on five consecutive days after loading dose, which was statistically significant. Time taken to establish full feeds following treatment initiation was lower in group 1 compared to group 2 (median: Two vs four days) which was statistically significant.Conclusions: In this study, neonates who received twice daily maintenance dose of caffeine citrate had better outcomes in terms of early reduction in number of apneic episodes and early feed establishment when co
简介:枸橼酸咖啡因被广泛用于预防早产儿呼吸暂停,并有助于成功地从机械通气拔管。早产儿呼吸暂停的最佳咖啡因剂量已被广泛研究,结果各不相同。本研究的目的是比较每日一次枸橼酸咖啡因维持剂量与每日两次枸橼酸咖啡因维持剂量对早产儿呼吸暂停的疗效和安全性。方法:本研究纳入胎龄28 ~ 34周,有早产呼吸暂停迹象的早产儿。两组均给予20 mg / kg负荷剂量的枸橼酸咖啡因,然后第1组每隔12小时给予2.5 mg / kg维持剂量,第2组每隔24小时给予5 mg / kg维持剂量,口服或静脉滴注。评估并比较两组患者对治疗的反应、达到完全喂养的时间、可能出现的不良反应。结果:两组中,1组在负荷剂量后连续5天呼吸暂停发作次数早期减少,差异有统计学意义。与2组相比,1组在治疗开始后建立完全饲料所需的时间更短(中位数:2天vs 4天),这具有统计学意义。结论:在本研究中,接受每日两次枸橼酸咖啡因维持剂量的新生儿在早期减少呼吸暂停发作次数和早期喂养建立方面具有更好的结果
{"title":"The Efficacy and Safety of Once Daily versus Twice Daily Dosing of Caffeine Citrate in Apnea of prematurity: a Randomised Control Tria","authors":"Farooq Syed, Sandesh Kini, Abdul Majeed","doi":"10.3126/jnps.v42i1.37173","DOIUrl":"https://doi.org/10.3126/jnps.v42i1.37173","url":null,"abstract":"Introduction: Caffeine citrate is widely used for prevention of apnea of prematurity and helps in successful extubation from mechanical ventilation. The optimum caffeine dose in preterm infants with apnea of prematurity has been extensively investigated with varied results. The objective of our study was to compare the efficacy and safety of once versus twice daily maintenance dose of caffeine citrate in premature infants with apnea.\u0000Methods: In this study, preterm neonates with gestational age of 28 to 34 weeks, with evidence of apnea of prematurity were included. Both groups received a 20 mg / kg loading dose of caffeine citrate followed by a maintenance dose of 2.5 mg / kg every 12-hour-interval in group 1 and 5 mg / kg every 24-hour-interval in group 2, either orally or by intravenous infusion. Response to treatment, duration to achieve full feeds, possible adverse reactions were evaluated and compared among the two groups.\u0000Results: Among two groups, group 1 had early reduction in number of apneic episodes on five consecutive days after loading dose, which was statistically significant. Time taken to establish full feeds following treatment initiation was lower in group 1 compared to group 2 (median: Two vs four days) which was statistically significant.\u0000Conclusions: In this study, neonates who received twice daily maintenance dose of caffeine citrate had better outcomes in terms of early reduction in number of apneic episodes and early feed establishment when co","PeriodicalId":39140,"journal":{"name":"Journal of Nepal Paediatric Society","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45620445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship Between Gross Motor Function and Nutritional Status in Children with Cerebral Palsy attending a Tertiary Children’s Hospital of Nepal 尼泊尔某三级儿童医院脑瘫患儿粗大运动功能与营养状况的关系
Q4 Medicine Pub Date : 2022-11-27 DOI: 10.3126/jnps.v42i1.38130
Suraj Dhaubhadel, Bina Prajapati, D. Nepal
Introduction: Malnutrition is a common problem in children with cerebral palsy and their management outcome is not satisfactory unless we address their nutritional aspect. The present study aims to find the relationship between gross motor function and nutritional status in these children by comparing the proportion of stunting, wasting and under-weight between the various levels of gross motor function.Methods: Our study was across- sectional study conducted on 82 cases of cerebral palsy between one to five years of age visiting Kanti Children’s Hospital, Kathmandu, Nepal from May 2017 to September 2018. Their level of gross motor function was ascertained by applying the Gross Motor Function Classification System (GMFCS) and anthropometry was done using standard methods. On the basis of their motor function, the children were divided into two categories: those with poorer motor function who had poor self-mobility even with assistance (GMFCS level 4 and 5) and those with better motor function who had self-mobility with various degrees of assistance (GMFCS level 1, 2 and 3). Wasting, stunting and under-weight were compared between the two categories and odds ratio with 95% confidence interval was estimated for malnutrition.Results: The children belonging to poorer motor function were more likely to be underweight (Odds ratio 3.41; CI 1.36-8.52; p-value 0.008) and stunted (Odds ratio 3.9; CI 1.47-10.53; p-value 0.048) than those with better motor function.Conclusions: Children with poorer motor function are more likely to develop malnutrition (Specially stunting) than those with better motor function indicating that chronic form of malnutrition is more common in these children.
引言:营养不良是脑瘫儿童的常见问题,除非我们解决他们的营养问题,否则他们的治疗结果并不令人满意。本研究旨在通过比较不同水平的毛运动功能中发育迟缓、消瘦和体重不足的比例,找出这些儿童的毛运动机能与营养状况之间的关系。方法:我们的研究是对2017年5月至2018年9月在尼泊尔加德满都Kanti儿童医院就诊的82例1至5岁脑瘫患者进行的横断面研究。通过应用总运动功能分类系统(GMFCS)确定他们的总运动功能水平,并使用标准方法进行人体测量。根据他们的运动功能,将儿童分为两类:运动功能较差的儿童,即使在有帮助的情况下自我活动能力较差(GMFCS 4级和5级);运动功能较好的儿童,在不同程度的帮助下自我活动(GMFCS 1级、2级和3级)。比较两类患者的消瘦、发育迟缓和体重不足,并估计营养不良的优势比为95%置信区间。结果:运动功能较差的儿童比运动功能较好的儿童更容易体重不足(比值比3.41;CI 1.36-8.52;p值0.008)和发育迟缓(比值比3.9;CI 1.47-10.53;p值0.048)。结论:运动功能较差的儿童比运动功能较好的儿童更容易出现营养不良(特别是发育迟缓),这表明慢性营养不良在这些儿童中更常见。
{"title":"Relationship Between Gross Motor Function and Nutritional Status in Children with Cerebral Palsy attending a Tertiary Children’s Hospital of Nepal","authors":"Suraj Dhaubhadel, Bina Prajapati, D. Nepal","doi":"10.3126/jnps.v42i1.38130","DOIUrl":"https://doi.org/10.3126/jnps.v42i1.38130","url":null,"abstract":"Introduction: Malnutrition is a common problem in children with cerebral palsy and their management outcome is not satisfactory unless we address their nutritional aspect. The present study aims to find the relationship between gross motor function and nutritional status in these children by comparing the proportion of stunting, wasting and under-weight between the various levels of gross motor function.\u0000Methods: Our study was across- sectional study conducted on 82 cases of cerebral palsy between one to five years of age visiting Kanti Children’s Hospital, Kathmandu, Nepal from May 2017 to September 2018. Their level of gross motor function was ascertained by applying the Gross Motor Function Classification System (GMFCS) and anthropometry was done using standard methods. On the basis of their motor function, the children were divided into two categories: those with poorer motor function who had poor self-mobility even with assistance (GMFCS level 4 and 5) and those with better motor function who had self-mobility with various degrees of assistance (GMFCS level 1, 2 and 3). Wasting, stunting and under-weight were compared between the two categories and odds ratio with 95% confidence interval was estimated for malnutrition.\u0000Results: The children belonging to poorer motor function were more likely to be underweight (Odds ratio 3.41; CI 1.36-8.52; p-value 0.008) and stunted (Odds ratio 3.9; CI 1.47-10.53; p-value 0.048) than those with better motor function.\u0000Conclusions: Children with poorer motor function are more likely to develop malnutrition (Specially stunting) than those with better motor function indicating that chronic form of malnutrition is more common in these children.","PeriodicalId":39140,"journal":{"name":"Journal of Nepal Paediatric Society","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47086872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extrauterine Growth Restriction among Very Low Birth Weight Neonate using Intergrowth 21st in a Neonatal Intensive Care Unit: A Retrospective Study 新生儿重症监护室使用Intergrowth 21st对极低出生体重新生儿子宫外生长限制的回顾性研究
Q4 Medicine Pub Date : 2022-11-27 DOI: 10.3126/jnps.v42i1.41526
S. Panda, B. Meher, Pravati Jena, D. Pradhan, S. Priyadarshini
Introduction: Extrauterine growth restriction (EUGR) is a universal problem but its prevalence using recent reference growth charts and morbidities associated with it are lacking. The study aims at estimating EUGR prevalence in very low birth weight (VLBW) neonates and its associated morbidities.Methods: All VLBW neonates admitted to NICU between Jan 2018 to June 2019 were analysed. Neonatal anthropometries were recorded on Intergrowth 21st gender based postnatal growth chart. EUGR was defined by weight below 10th percentile at discharge. Demographic profile and neonatal morbidities were compared between EUGR and non-EUGR by using unpaired t test and Chi-square test. Regression was used for identification of the risk factors.Results: Out of 148 VLBW neonates, 92 (62.1%) were male, 26 (17.56%) were below 1000 gm, 102 (68%) were EUGR at discharge. Mean (SD) birth weight and gestational age were 1202 (221) gms and 30.89 (2.77) wks respectively. Caesarean delivery, higher gestational age, lower birth weight, SGA at birth and prolonged duration to achieve full enteral feeding were significantly associated with EUGR (P < 0.05). Sepsis was significantly associated with EUGR (36.28% vs. 17.4%; P 0.022). EUGR babies needed longer hospital duration (24.56% vs. 16.78%; P 0.005) with a higher mean PMA at discharge (38.07 wks vs. 35.11 wks; P < 0.001). In regression model SGA at birth and delay in achieving full feeding were independent predictor of EUGR. Conclusions: In VLBW neonate, prevalence of EUGR at discharge was 68%. Sepsis was significantly associated with EUGR. SGA and delay in achieving full feeding were independent predictors of EUGR.
引言:子宫外生长受限(EUGR)是一个普遍存在的问题,但使用最近的参考生长图及其相关的发病率缺乏。该研究旨在估计极低出生体重(VLBW)新生儿的EUGR患病率及其相关疾病。方法:对2018年1月至2019年6月入住新生儿重症监护室的所有极低出生体重新生儿进行分析。新生儿的人体测量记录在Intergrowth 21基于性别的产后生长图上。EUGR定义为出院时体重低于第10百分位。采用不配对t检验和卡方检验比较EUGR和非EUGR的人口统计学特征和新生儿发病率。采用回归法对危险因素进行识别。结果:在148例极低出生体重新生儿中,92例(62.1%)为男性,26例(17.56%)低于1000克,102例(68%)出院时为EUGR。平均出生体重和胎龄分别为1202(221)克和30.89(2.77)周。剖腹产,较高的胎龄,较低的出生体重,出生时的SGA和长时间实现全肠内喂养与EUGR显著相关(P<0.05)。败血症与EUGR明显相关(36.28%对17.4%;P 0.022)。EUGR婴儿需要更长的住院时间(24.56%对16.78%;P 0.005),出院时的平均PMA更高(38.07周对35.11周;P<0.001)。在回归模型中,出生时SGA和延迟实现完全喂养是EUGR的独立预测因子。结论:极低出生体重新生儿出院时发生EUGR的发生率为68%。脓毒症与EUGR显著相关。SGA和延迟完全进食是EUGR的独立预测因素。
{"title":"Extrauterine Growth Restriction among Very Low Birth Weight Neonate using Intergrowth 21st in a Neonatal Intensive Care Unit: A Retrospective Study","authors":"S. Panda, B. Meher, Pravati Jena, D. Pradhan, S. Priyadarshini","doi":"10.3126/jnps.v42i1.41526","DOIUrl":"https://doi.org/10.3126/jnps.v42i1.41526","url":null,"abstract":"Introduction: Extrauterine growth restriction (EUGR) is a universal problem but its prevalence using recent reference growth charts and morbidities associated with it are lacking. The study aims at estimating EUGR prevalence in very low birth weight (VLBW) neonates and its associated morbidities.\u0000Methods: All VLBW neonates admitted to NICU between Jan 2018 to June 2019 were analysed. Neonatal anthropometries were recorded on Intergrowth 21st gender based postnatal growth chart. EUGR was defined by weight below 10th percentile at discharge. Demographic profile and neonatal morbidities were compared between EUGR and non-EUGR by using unpaired t test and Chi-square test. Regression was used for identification of the risk factors.\u0000Results: Out of 148 VLBW neonates, 92 (62.1%) were male, 26 (17.56%) were below 1000 gm, 102 (68%) were EUGR at discharge. Mean (SD) birth weight and gestational age were 1202 (221) gms and 30.89 (2.77) wks respectively. Caesarean delivery, higher gestational age, lower birth weight, SGA at birth and prolonged duration to achieve full enteral feeding were significantly associated with EUGR (P < 0.05). Sepsis was significantly associated with EUGR (36.28% vs. 17.4%; P 0.022). EUGR babies needed longer hospital duration (24.56% vs. 16.78%; P 0.005) with a higher mean PMA at discharge (38.07 wks vs. 35.11 wks; P < 0.001). In regression model SGA at birth and delay in achieving full feeding were independent predictor of EUGR.\u0000 Conclusions: In VLBW neonate, prevalence of EUGR at discharge was 68%. Sepsis was significantly associated with EUGR. SGA and delay in achieving full feeding were independent predictors of EUGR.","PeriodicalId":39140,"journal":{"name":"Journal of Nepal Paediatric Society","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46556153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcutaneous Bilirubin Measurement as a Predictor of Significant Neonatal Hyperbilirubinemia in Low Birth Weight Neonates 经皮胆红素测量作为低出生体重新生儿显著高胆红素血症的预测因子
Q4 Medicine Pub Date : 2022-11-27 DOI: 10.3126/jnps.v42i1.38236
Suchetha S Rao, Karthik Chellaganapathy, N. Kamath
Introduction: Early recognition of neonatal hyperbilirubinemia is essential to prevent bilirubin encephalopathy. Transcutaneous bilirubin (TCB) measurement is a simple and easy method to predict neonatal hyperbilirubinemia. We aimed to study the efficacy of TCB as a predictor of subsequent significant neonatal hyperbilirubinemia in low birth neonates and compared the forehead and sternal sites for TCB measurement.Methods: A prospective study was conducted from August to October 2018 at a teaching hospital in South India including term and late preterm neonates weighing < 2.5 kg. The TCB values were obtained from the forehead (TCB-FH) and sternum (TCB-S) by a non-Invasive Bilirubin Analyser. The average of TCB (TCB- AV) was determined for each baby with TCB-FH and TCB –S values. Neonates were followed up subsequently till discharge for the development of significant hyperbilirubinemia. Receiver operating characteristic (ROC) curve was generated and the best cut-off value for 24-hour TCB as a predictor of significant hyperbilirubinemia was established.Results: The study included 88 neonates, of which 39 (44.3%) were late preterm and 49 (55.7%) term small for gestation age. Mean values of TCB –AV 6.25 ± 1.58, TCB – FH 6.24 ± 1.57391, and TCB – S 6.27 ± 1.56 were noted. The cut off value for TCB – AV was found to be 6.85 as a predictor for subsequent neonatal hyperbilirubinemia. TCB – AV was a better predictor than TCB - FH or TCB – S.Conclusions: TCB measurement is an easy and reliable predictor for subsequent significant hyperbilirubinemia in low birth weight neonates. The average of TCB forehead and sternum was a better predictor of significant hyperbilirubinemia.
早期识别新生儿高胆红素血症对预防胆红素脑病至关重要。经皮胆红素(TCB)测定是预测新生儿高胆红素血症的一种简单易行的方法。我们的目的是研究TCB作为低出生新生儿后续显著新生儿高胆红素血症预测因子的有效性,并比较了TCB测量的前额和胸骨部位。方法:2018年8月至10月在印度南部的一家教学医院进行了一项前瞻性研究,包括体重< 2.5 kg的足月和晚期早产儿。通过无创胆红素分析仪从前额(TCB- fh)和胸骨(TCB- s)获得TCB值。测定TCB- fh和TCB- s值患儿TCB (TCB- AV)平均值。随后对新生儿进行随访,直至出院,以检查是否出现明显的高胆红素血症。生成受试者工作特征(ROC)曲线,并建立24小时TCB作为显著高胆红素血症预测指标的最佳临界值。结果:本组共纳入88例新生儿,其中晚期早产39例(44.3%),小于胎龄足月49例(55.7%)。TCB - av平均值为6.25±1.58,TCB - FH平均值为6.24±1.57391,TCB - S平均值为6.27±1.56。发现TCB - AV的截断值为6.85,作为随后新生儿高胆红素血症的预测因子。TCB - AV比TCB - FH或TCB - s更能预测低出生体重儿是否出现显著高胆红素血症。前额和胸骨TCB的平均值是显著高胆红素血症的较好预测指标。
{"title":"Transcutaneous Bilirubin Measurement as a Predictor of Significant Neonatal Hyperbilirubinemia in Low Birth Weight Neonates","authors":"Suchetha S Rao, Karthik Chellaganapathy, N. Kamath","doi":"10.3126/jnps.v42i1.38236","DOIUrl":"https://doi.org/10.3126/jnps.v42i1.38236","url":null,"abstract":"Introduction: Early recognition of neonatal hyperbilirubinemia is essential to prevent bilirubin encephalopathy. Transcutaneous bilirubin (TCB) measurement is a simple and easy method to predict neonatal hyperbilirubinemia. We aimed to study the efficacy of TCB as a predictor of subsequent significant neonatal hyperbilirubinemia in low birth neonates and compared the forehead and sternal sites for TCB measurement.\u0000Methods: A prospective study was conducted from August to October 2018 at a teaching hospital in South India including term and late preterm neonates weighing < 2.5 kg. The TCB values were obtained from the forehead (TCB-FH) and sternum (TCB-S) by a non-Invasive Bilirubin Analyser. The average of TCB (TCB- AV) was determined for each baby with TCB-FH and TCB –S values. Neonates were followed up subsequently till discharge for the development of significant hyperbilirubinemia. Receiver operating characteristic (ROC) curve was generated and the best cut-off value for 24-hour TCB as a predictor of significant hyperbilirubinemia was established.\u0000Results: The study included 88 neonates, of which 39 (44.3%) were late preterm and 49 (55.7%) term small for gestation age. Mean values of TCB –AV 6.25 ± 1.58, TCB – FH 6.24 ± 1.57391, and TCB – S 6.27 ± 1.56 were noted. The cut off value for TCB – AV was found to be 6.85 as a predictor for subsequent neonatal hyperbilirubinemia. TCB – AV was a better predictor than TCB - FH or TCB – S.\u0000Conclusions: TCB measurement is an easy and reliable predictor for subsequent significant hyperbilirubinemia in low birth weight neonates. The average of TCB forehead and sternum was a better predictor of significant hyperbilirubinemia.","PeriodicalId":39140,"journal":{"name":"Journal of Nepal Paediatric Society","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48981713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Chylolymphatic Cyst - Presenting as Acute Intestinal Obstruction – A Case Report 乳糜淋巴囊肿-表现为急性肠梗阻1例
Q4 Medicine Pub Date : 2022-11-27 DOI: 10.3126/jnps.v42i1.38679
Sunita Arora, T. Kaur, Harwinder Singh Rana
Chylolymphatic cyst is one of the rare variants of mesenteric cysts. These cysts are present within mesentery and contain chylous or lymphatic fluid. Chylolymphatic cysts are rare in paediatric age group. We present a case of a four years old boy who presented with features of acute intestinal obstruction. CECT abdomen revealed a hypodense cystic mass in the peritoneal cavity. Exploratory laparotomy of the abdomen revealed a solitary cyst measuring 10.7 cm x 9.4 cm x 10.5 cm which was adherent to the loops of small intestine and right kidney. Complete excision of cyst along with resection of the adjacent gut and end to end anastomosis was done. Histopathology of the excised cyst was suggestive of chylolymphatic cyst. It has been highlighted that chylolymphatic cyst can be a rare cause of intestinal obstruction in children.
糜淋巴囊肿是肠系膜囊肿的一种罕见变异。这些囊肿存在于肠系膜内,含有乳糜或淋巴液。乳糜淋巴囊肿在儿科年龄组中很少见。我们报告一个四岁男孩的病例,他表现出急性肠梗阻的特征。CECT腹部显示腹膜腔内有一个低密度囊性肿块。腹部探查术发现一个10.7厘米x 9.4厘米x 10.5厘米的孤立囊肿,附着在小肠和右肾环上。完全切除囊肿,同时切除邻近的肠道并端对端吻合。切除囊肿的组织病理学提示为糜淋巴囊肿。有人强调,乳糜淋巴囊肿可能是儿童肠梗阻的一种罕见原因。
{"title":"Chylolymphatic Cyst - Presenting as Acute Intestinal Obstruction – A Case Report","authors":"Sunita Arora, T. Kaur, Harwinder Singh Rana","doi":"10.3126/jnps.v42i1.38679","DOIUrl":"https://doi.org/10.3126/jnps.v42i1.38679","url":null,"abstract":"Chylolymphatic cyst is one of the rare variants of mesenteric cysts. These cysts are present within mesentery and contain chylous or lymphatic fluid. Chylolymphatic cysts are rare in paediatric age group. We present a case of a four years old boy who presented with features of acute intestinal obstruction. CECT abdomen revealed a hypodense cystic mass in the peritoneal cavity. Exploratory laparotomy of the abdomen revealed a solitary cyst measuring 10.7 cm x 9.4 cm x 10.5 cm which was adherent to the loops of small intestine and right kidney. Complete excision of cyst along with resection of the adjacent gut and end to end anastomosis was done. Histopathology of the excised cyst was suggestive of chylolymphatic cyst. It has been highlighted that chylolymphatic cyst can be a rare cause of intestinal obstruction in children.","PeriodicalId":39140,"journal":{"name":"Journal of Nepal Paediatric Society","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48006750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome of Surfactant replacement therapy for respiratory distress syndrome in preterm babies 表面活性剂替代治疗早产儿呼吸窘迫综合征的疗效
Q4 Medicine Pub Date : 2022-11-27 DOI: 10.3126/jnps.v42i1.38218
P. Kansakar, Narottam Shrestha, Alisha Prajapati, Shiva Prasad Chalise, Santosh Kumar Mishra
Introduction: Surfactant is an important treatment modality in preterm babies with respiratory distress syndrome leading to decrease in mortality, morbidity and cost of treatment. Experiences on surfactant therapy in Nepal are scarce. This study was conceptualised to find the use and immediate outcome of surfactant therapy in preterm babies in a tertiary care hospital in Nepal.Methods: A cross-sectional study was done in preterm babies who received surfactant over period of five years at neonatal / pediatric intensive care unit at Patan Hospital, Lalitpur, Nepal. After approval from Institutional review committee, information on gestational age, sex, birth weight, doses of dexamethasone, doses and time surfactant delivery, complications and immediate outcome was retrieved from the files. Comparison between early and late rescue group was done. Data was analysed using SPSS 16.Results: Twelve babies (11.2%) needed a repeat dose of surfactant. Only 12 (11.2%) babies received early rescue surfactant. About 53 (49.5%) babies developed complications with hypotension being the most common seen in 38 (35.5%) babies. Complications were 75% and 46% in the early and late rescue group respectively (p - 0.22). The mortality was inversely proportional to the gestational age (p - 0.002) and birth weight (p < 0.05). Mortality was 16% in both the groups but the deaths related to complications of surfactant was all in the late rescue group.Conclusions: Complications were more in early rescue group and mortality was similar in both the groups, but mortality related to complications of surfactant was all in the late rescue group. Complications of surfactant therapy and mortality were inversely proportional to the gestational age and birth weight.
表面活性剂是早产儿呼吸窘迫综合征的一种重要治疗方式,可降低死亡率、发病率和治疗费用。在尼泊尔,表面活性剂治疗的经验很少。本研究的概念是发现使用表面活性剂治疗早产儿在尼泊尔三级护理医院的直接结果。方法:对尼泊尔拉利特普尔帕坦医院新生儿/儿科重症监护室接受表面活性剂治疗5年以上的早产儿进行横断面研究。经机构审查委员会批准后,从档案中检索有关胎龄、性别、出生体重、地塞米松剂量、表面活性剂给药剂量和时间、并发症和即时结果的信息。对早期和晚期抢救组进行比较。数据采用SPSS 16进行分析。结果:12例(11.2%)患儿需要重复给药。仅有12例(11.2%)婴儿接受了早期救助表面活性剂。约53例(49.5%)患儿出现并发症,其中38例(35.5%)患儿最常见低血压。早期和晚期抢救组并发症发生率分别为75%和46% (p = 0.22)。死亡率与胎龄(p - 0.002)和出生体重(p < 0.05)成反比。两组死亡率均为16%,但与表面活性剂并发症相关的死亡均发生在晚期抢救组。结论:早期抢救组并发症较多,两组死亡率相近,但与表面活性剂并发症相关的死亡率在晚期抢救组均无差异。表面活性剂治疗并发症和死亡率与胎龄和出生体重成反比。
{"title":"Outcome of Surfactant replacement therapy for respiratory distress syndrome in preterm babies","authors":"P. Kansakar, Narottam Shrestha, Alisha Prajapati, Shiva Prasad Chalise, Santosh Kumar Mishra","doi":"10.3126/jnps.v42i1.38218","DOIUrl":"https://doi.org/10.3126/jnps.v42i1.38218","url":null,"abstract":"Introduction: Surfactant is an important treatment modality in preterm babies with respiratory distress syndrome leading to decrease in mortality, morbidity and cost of treatment. Experiences on surfactant therapy in Nepal are scarce. This study was conceptualised to find the use and immediate outcome of surfactant therapy in preterm babies in a tertiary care hospital in Nepal.\u0000Methods: A cross-sectional study was done in preterm babies who received surfactant over period of five years at neonatal / pediatric intensive care unit at Patan Hospital, Lalitpur, Nepal. After approval from Institutional review committee, information on gestational age, sex, birth weight, doses of dexamethasone, doses and time surfactant delivery, complications and immediate outcome was retrieved from the files. Comparison between early and late rescue group was done. Data was analysed using SPSS 16.\u0000Results: Twelve babies (11.2%) needed a repeat dose of surfactant. Only 12 (11.2%) babies received early rescue surfactant. About 53 (49.5%) babies developed complications with hypotension being the most common seen in 38 (35.5%) babies. Complications were 75% and 46% in the early and late rescue group respectively (p - 0.22). The mortality was inversely proportional to the gestational age (p - 0.002) and birth weight (p < 0.05). Mortality was 16% in both the groups but the deaths related to complications of surfactant was all in the late rescue group.\u0000Conclusions: Complications were more in early rescue group and mortality was similar in both the groups, but mortality related to complications of surfactant was all in the late rescue group. Complications of surfactant therapy and mortality were inversely proportional to the gestational age and birth weight.","PeriodicalId":39140,"journal":{"name":"Journal of Nepal Paediatric Society","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46741299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperbaric Oxygen Therapy : A new Evolving Future Perspective for Management of Mucormycosis and COVID 19 in Children in Developing Countries 高压氧治疗:发展中国家儿童毛霉病和COVID - 19治疗的新前景
Q4 Medicine Pub Date : 2022-11-27 DOI: 10.3126/jnps.v42i1.42443
M. Lakra, A. Taksande, B. Lakhkar, Sachin Damke, Ashwini Lakra
The SARS COVID-19 virus has arisen as a major hazard to mankind, posing harm to the whole world population. During the second COVID wave, mucormycosis has emerged as one of the deadliest and most devastating illnesses. Mucormycosis is strongly associated with diabetes, prolonged use of steroids, prolonged hospitalisation and immunocompromised states. Children have also been affected by this badly. Hyperbaric oxygen therapy is a non-invasive, cost-effective and painless therapy where 100% oxygen is given to patients under high atmospheric pressure in small tents or chambers. It helps in tissue regeneration and angiogenesis. Hyperbaric oxygen has proved to be effective in the treatment of oculo-rhino-cerebral mucormycosis. Various studies have proved its role in the management of mucormycosis and acute respiratory distress syndrome associated with COVID-19 infection. The advantages of hyperbaric oxygen are same in children as in adults with minimum side effects. Hyperbaric oxygen therapy can be one of the good adjunctive therapies in the management of mucormycosis. It is found to be safe in the treatment of COVID-19 infection, but data is still limited on its use and further studies are needed. This article is all about its use, its efficacy, and future perspectives in the management of mucormycosis and COVID-19 in view of the arrival of the third COVID wave in developing countries like India.
新冠肺炎疫情已成为人类面临的重大危害,危及全世界人民。在第二波疫情中,毛霉病已成为最致命和最具破坏性的疾病之一。毛霉病与糖尿病、长期使用类固醇、长期住院和免疫功能低下状态密切相关。儿童也受到严重影响。高压氧治疗是一种无创、经济、无痛的治疗方法,在小帐篷或小房间的高压下给患者100%的氧气。它有助于组织再生和血管生成。高压氧已被证明是有效的治疗眼鼻脑毛霉菌病。多项研究已证明其在治疗与COVID-19感染相关的毛霉病和急性呼吸窘迫综合征中的作用。高压氧对儿童和成人的好处是一样的,副作用最小。高压氧治疗是治疗毛霉病较好的辅助治疗方法之一。已发现它在治疗COVID-19感染方面是安全的,但其使用数据仍然有限,需要进一步研究。鉴于第三波COVID-19在印度等发展中国家的到来,本文将介绍其在毛霉病和COVID-19管理中的使用、疗效和未来展望。
{"title":"Hyperbaric Oxygen Therapy : A new Evolving Future Perspective for Management of Mucormycosis and COVID 19 in Children in Developing Countries","authors":"M. Lakra, A. Taksande, B. Lakhkar, Sachin Damke, Ashwini Lakra","doi":"10.3126/jnps.v42i1.42443","DOIUrl":"https://doi.org/10.3126/jnps.v42i1.42443","url":null,"abstract":"The SARS COVID-19 virus has arisen as a major hazard to mankind, posing harm to the whole world population. During the second COVID wave, mucormycosis has emerged as one of the deadliest and most devastating illnesses. Mucormycosis is strongly associated with diabetes, prolonged use of steroids, prolonged hospitalisation and immunocompromised states. Children have also been affected by this badly. Hyperbaric oxygen therapy is a non-invasive, cost-effective and painless therapy where 100% oxygen is given to patients under high atmospheric pressure in small tents or chambers. It helps in tissue regeneration and angiogenesis. Hyperbaric oxygen has proved to be effective in the treatment of oculo-rhino-cerebral mucormycosis. Various studies have proved its role in the management of mucormycosis and acute respiratory distress syndrome associated with COVID-19 infection. The advantages of hyperbaric oxygen are same in children as in adults with minimum side effects. Hyperbaric oxygen therapy can be one of the good adjunctive therapies in the management of mucormycosis. It is found to be safe in the treatment of COVID-19 infection, but data is still limited on its use and further studies are needed. This article is all about its use, its efficacy, and future perspectives in the management of mucormycosis and COVID-19 in view of the arrival of the third COVID wave in developing countries like India.","PeriodicalId":39140,"journal":{"name":"Journal of Nepal Paediatric Society","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43407304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and Risk Factors Association for Ventilator Associated Pneumonia in Neontal Intensive Care Unit 新生儿重症监护病房呼吸机相关性肺炎的发病率及危险因素
Q4 Medicine Pub Date : 2022-11-27 DOI: 10.3126/jnps.v42i1.38603
Naresh Kumar, P. Malhotra, Amanjeet Kaur Bagga, Gagandeep Kaur
Introduction: Ventilator Associated Pneumonia (VAP), the nosocomial pneumonia developing in mechanically ventilated patients after 48 hours of mechanical ventilation, is the second commonest nosocomial infection in the neonatal intensive care unit (NICU). VAP occurring within 96 hours of initiation of mechanical ventilation is termed as early VAP and later than that is known as late VAP. The aim of this study was to determine the incidence rate and risk factors of early and late ventilator associated pneumonia in NICU.Methods: The study was conducted from December 2015 to November 2017 in which 40 neonates were ventilated for more than 48 hours of which those who developed VAP as per CDC criteria were enrolled in the study. Birth weight, gestation age, reintubation if needed and number of days of ventilation were noted. Statistical associations were further evaluated between various parameters of VAP and time of development of VAP.Results: Incidence of Early VAP was 12.5% and that of Late VAP was 87.5%. 93.95% neonates who were reintubated developed VAP. Duration of mechanical ventilation and re-intubation were significantly associated with the time of development of VAP. Birth weight and gestation age were statistically insignificant factors in determining VAP.Conclusions: Re-intubation and duration of mechanical ventilation are a significant risk factor for development of late VAP. Gestation age and birth weight have been identified as additional risk factors. Early diagnosis is necessary for appropriate treatment and decreased hospital stay.
引言:呼吸机相关性肺炎(VAP)是指机械通气患者在机械通气48小时后发生的医院感染,是新生儿重症监护室(NICU)第二常见的医院感染。在开始机械通气后96小时内发生的VAP被称为早期VAP,晚于此时间被称为晚期VAP。本研究的目的是确定新生儿重症监护室早期和晚期呼吸机相关肺炎的发病率和危险因素。方法:本研究于2015年12月至2017年11月进行,共有40名新生儿通气超过48小时,其中根据美国疾病控制与预防中心标准出现VAP的新生儿被纳入本研究。记录出生体重、妊娠年龄、必要时再次插管和通气天数。结果:早期VAP的发生率为12.5%,晚期VAP的发病率为87.5%,93.95%的新生儿再次插管后发生VAP。机械通气和再次插管的持续时间与VAP的发生时间显著相关。出生体重和妊娠年龄是决定VAP的统计学上不重要的因素。结论:再次插管和机械通气时间是发展为晚期VAP的重要危险因素。妊娠年龄和出生体重已被确定为额外的风险因素。早期诊断对于适当的治疗和减少住院时间是必要的。
{"title":"Incidence and Risk Factors Association for Ventilator Associated Pneumonia in Neontal Intensive Care Unit","authors":"Naresh Kumar, P. Malhotra, Amanjeet Kaur Bagga, Gagandeep Kaur","doi":"10.3126/jnps.v42i1.38603","DOIUrl":"https://doi.org/10.3126/jnps.v42i1.38603","url":null,"abstract":"Introduction: Ventilator Associated Pneumonia (VAP), the nosocomial pneumonia developing in mechanically ventilated patients after 48 hours of mechanical ventilation, is the second commonest nosocomial infection in the neonatal intensive care unit (NICU). VAP occurring within 96 hours of initiation of mechanical ventilation is termed as early VAP and later than that is known as late VAP. The aim of this study was to determine the incidence rate and risk factors of early and late ventilator associated pneumonia in NICU.\u0000Methods: The study was conducted from December 2015 to November 2017 in which 40 neonates were ventilated for more than 48 hours of which those who developed VAP as per CDC criteria were enrolled in the study. Birth weight, gestation age, reintubation if needed and number of days of ventilation were noted. Statistical associations were further evaluated between various parameters of VAP and time of development of VAP.\u0000Results: Incidence of Early VAP was 12.5% and that of Late VAP was 87.5%. 93.95% neonates who were reintubated developed VAP. Duration of mechanical ventilation and re-intubation were significantly associated with the time of development of VAP. Birth weight and gestation age were statistically insignificant factors in determining VAP.\u0000Conclusions: Re-intubation and duration of mechanical ventilation are a significant risk factor for development of late VAP. Gestation age and birth weight have been identified as additional risk factors. Early diagnosis is necessary for appropriate treatment and decreased hospital stay.","PeriodicalId":39140,"journal":{"name":"Journal of Nepal Paediatric Society","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42807257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Nepal Paediatric Society
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1